前端編輯

管理員身份可於登入後,進行網站的前端管理。

2nd  Circulating Tumor Cells and Liquid Biopsy San Francisco, United States of America 

March 2-4

Circulating tumor cells and cell-free tumor DNA have dominated the headlines for the past decade and presently new liquid biopsy tests are entering the clinic. These will enable improved diagnosis of cancer, early detection, and a new era of companion diagnostics for therapy selection, monitoring, predicting outcomes, and measuring the risk of recurrence. New tools include methods to both isolate CTCs and destroy them with lasers, digital microfluidics, and epigenetic measurement to better diagnose, prognose, and treat disease.

Go to top